Literature DB >> 15188141

Infantile hemangioma is a proliferation of beta 4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology.

Van Anh Nguyen1, Christina Fürhapter, Nikolaus Romani, Florian Weber, Norbert Sepp.   

Abstract

Although hemangioma is referred as to the most common tumor in infancy, the underlying pathogenetic events and the biologic origin of this benign vascular neoplasm have remained obscure. By using immunohistochemistry on frozen sections of infantile hemangiomas, we show here that proliferating endothelial cells abundantly expressed alpha(v)beta(3) but lacked beta(4) integrins. Instead, regressing and involuting infantile hemangiomas due to treatment with IFN-alpha showed positive staining of beta(4) integrin, which might point to the angiogenic significance of beta(4) integrin in infantile hemangiomas. Moreover, immunofluorescence analysis revealed the existence of HLA-DR(+), mostly CD68(+) and partly DC-SIGN/CD209(+) cells with dendritic cell morphology in the intimate vicinity of hemangiomatous vessels. Such cells were also detected in the dermal microvascular unit in normal skin. The coupled occurrence of vascular structures and perivascular cells that were stained positive with markers of monocyte or macrophage or dendritic cells might suggest that the development of infantile hemangioma is a result of vasculogenesis, that is, the formation of primitive blood vessels from angioblasts, rather than of angiogenesis, that is, the sprouting of capillaries from preexisting vessels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188141     DOI: 10.1016/j.humpath.2004.02.005

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Overexpression of Notch1 ectodomain in myeloid cells induces vascular malformations through a paracrine pathway.

Authors:  Xiujie Li; Ezequiel Calvo; Marc Cool; Pavel Chrobak; Denis G Kay; Paul Jolicoeur
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Myeloid cells in infantile hemangioma.

Authors:  Matthew R Ritter; John Reinisch; Sheila Fallon Friedlander; Martin Friedlander
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Evidence by molecular profiling for a placental origin of infantile hemangioma.

Authors:  Carmen M Barnés; Sui Huang; Arja Kaipainen; Despina Sanoudou; Emy J Chen; Gabriel S Eichler; Yuchun Guo; Ying Yu; Donald E Ingber; John B Mulliken; Alan H Beggs; Judah Folkman; Steven J Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

4.  A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway.

Authors:  Masayuki Tsuneki; Steven Hardee; Michael Michaud; Raffaella Morotti; Erin Lavik; Joseph A Madri
Journal:  Lab Invest       Date:  2015-05-11       Impact factor: 5.662

5.  Effect of electrochemotherapy in treating patients with venous malformations.

Authors:  Jing-Hong Li; Yu-Ling Xin; Xue-Qiang Fan; Jie Chen; Jian Wang; Jin Zhou
Journal:  Chin J Integr Med       Date:  2013-03-15       Impact factor: 1.978

Review 6.  Vasculogenesis in infantile hemangioma.

Authors:  Elisa Boscolo; Joyce Bischoff
Journal:  Angiogenesis       Date:  2009-05-10       Impact factor: 9.596

Review 7.  Progenitor cells in infantile hemangioma.

Authors:  Joyce Bischoff
Journal:  J Craniofac Surg       Date:  2009-03       Impact factor: 1.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.